March/April 2008
19 New Articles
- Fast UHPLC Using Sub-2 μm Particles and Elevated Pressures for Pharmaceutical Process Development
Naijun Wu, Andrew Clausen, Lisa Wright, Kate Vogel, and Francis Bernardoni Merck &Co., Inc. - The Role of Isothermal Microcalorimetry in Solid-state Characterization and Formulation Screening in Pharmaceutical Development
Wenzhan Yang, Dedong Wu Pharmaceutical &Analytical R&D, AstraZeneca Pharmaceuticals - In Process Monitoring of Polymorphic Form Conversion by Raman Spectroscopy and Turbidity Measurements
Susan Barnes, Jason Gillian, Ann Diederich, Delphi Burton, Darryl Ertl GlaxoSmithKline - Monitoring Polymorphism of Drugs, an On-Going Challenge - Part 2
Danielle Giron Novartis Pharma AG - NIR as an In-Process Tool
Mark Bell Napp Pharmaceuticals Ltd
View Full Article List
Web Exclusives
- Meeting New Regulatory Expectations of Characterization Methods Qualification of Biophysical Analyses
Yijia Jiang, Cynthia Li, Ranjini Ramachander, Jie Wen, and Linda Owers Narhi Forensic and Biophysical Analysis, Global Cellular &Analytical Resources Department Amgen Inc. - Development of Freeze and Thaw Processes for Bulk Biologics in Disposable Bags
Kin Ho, Serguei Tchessalov, Angela Kantor, Nicholas Warne Drug Product Development, Wyeth Biopharma - Process Analytical Technology: A First Step in a Jouney Towards the Desired State
Ajaz S. Hussain, Ph.D.
Deputy Director, Office of Pharmaceutical Science
CDER, FDA
View More Web Exclusives
.gif)
